臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

About TAIR
	About TAIR

Browse By
	Institution
	Author
	Title
	Date
	Statistics Chart
	Institution Facts
	Trend

News
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

Copyright
	Publisher & Journal Policy
	TAIR Copyright Conference Minutes

Related Links
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"shao y y"

Return to Browse by Author
Sorting by Title	Sort by Date

Showing items 246-270 of 396 (16 Page(s) Totally)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2021-02-18T02:09:13Z	Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan	Shao Y.-Y.;Wang S.-Y.;Lin S.-M.;Chen K.-Y.;Tseng J.-H.;Ho M.-C.;Lee R.-C.;Liang P.-C.;Liao L.-Y.;Huang K.-W.;Hu J.-T.;Liang J.-D.;Kee K.-M.;Lin C.-L.;Wang C.-K.;Lu S.-N.;Wang J.-H.;Lee W.-C.;Chen C.-H.;Liu C.-J.;Huang Y.-H.;Wang C.-C.;Wang T.-E.;Chuang P.-H.;Dai C.-Y.;Chiun Hsu;Chen S.-C.;Hsieh C.-H.;Diagnosis Group, Systemic Therapy Group; Shao Y.-Y.; Wang S.-Y.; Lin S.-M.; Chen K.-Y.; Tseng J.-H.; Ho M.-C.; Lee R.-C.; Liang P.-C.; Liao L.-Y.; Huang K.-W.; Hu J.-T.; Liang J.-D.; Kee K.-M.; Lin C.-L.; Wang C.-K.; Lu S.-N.; Wang J.-H.; Lee W.-C.; Chen C.-H.; Liu C.-J.; Huang Y.-H.; Wang C.-C.; Wang T.-E.; Chuang P.-H.; Dai C.-Y.; Chiun Hsu; Chen S.-C.; Hsieh C.-H.; Diagnosis Group, Systemic Therapy Group
臺大學術典藏	2021-02-18T02:09:12Z	The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma	Hung Y.-P.;Shao Y.-Y.;Chiun Hsu;Lee J.-M.;Yang M.-H.;Chao Y.; Hung Y.-P.; Shao Y.-Y.; Chiun Hsu; Lee J.-M.; Yang M.-H.; Chao Y.
臺大學術典藏	2021-02-18T01:45:21Z	A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy	Lin Z.-Z.;Chen B.-B.;Hung Y.-P.;Huang P.-H.;Shen Y.-C.;Shao Y.-Y.;Chiun Hsu;Cheng A.-L.;Lee R.-C.;Chao Y.; Lin Z.-Z.; Chen B.-B.; Hung Y.-P.; Huang P.-H.; Shen Y.-C.; Shao Y.-Y.; Chiun Hsu; Cheng A.-L.; Lee R.-C.; Chao Y.
臺大學術典藏	2021-01-28T01:06:39Z	Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer	Lu L.-C.; Shao Y.-Y.; Hsu C.-H.; Hsu C.; Cheng W.-F.; Lin Y.-L.; Cheng A.-L.; KUN-HUEI YEH
臺大學術典藏	2021-01-28T01:06:34Z	Type 2 diabetes mellitus is associated with increased mortality in chinese patients receiving curative surgery for colon cancer	Chen K.-H.;Shao Y.-Y.;Lin Z.-Z.;Yeh Y.-C.;Wen-Yi S.;Kuo R.N.;Chen H.-M.;Lai C.-L.;Kun-Huei Yeh;Cheng A.-L.;Lai M.-S.; Chen K.-H.; Shao Y.-Y.; Lin Z.-Z.; Yeh Y.-C.; Wen-Yi S.; Kuo R.N.; Chen H.-M.; Lai C.-L.; KUN-HUEI YEH; Cheng A.-L.; Lai M.-S.
臺大學術典藏	2021-01-28T01:06:30Z	Young patients with colorectal cancer have increased risk of second primary cancers	Liang Y.-H.; Shao Y.-Y.; Chen H.-M.; Lai C.-L.; Lin Z.-Z.; Kuo R.N.; Cheng A.-L.; KUN-HUEI YEH; Lai M.-S.
臺大學術典藏	2021-01-28T01:06:29Z	Statin Use Is Associated With Improved Prognosis of Colorectal Cancer in Taiwan	Shao Y.-Y.; Hsu C.-H.; KUN-HUEI YEH; Chen H.-M.; Yeh Y.-C.; Lai C.-L.; Lin Z.-Z.; Cheng A.-L.; Lai M.-S.
臺大學術典藏	2021-01-28T01:06:27Z	Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: A nationwide cohort study	Chen K.-H.; Shao Y.-Y.; Chen H.-M.; Lin Y.-L.; Lin Z.-Z.; Lai M.-S.; Cheng A.-L.; KUN-HUEI YEH
臺大學術典藏	2021-01-28T01:06:25Z	Irinotecan and oxaliplatin might provide equal benefit as adjuvant chemotherapy for patients with resectable synchronous colon cancer and liver-confined metastases: A nationwide database study	Liang Y.-H.;Shao Y.-Y.;Chen H.-M.;Cheng A.-L.;Lai M.-S.;Kun-Huei Yeh; Liang Y.-H.; Shao Y.-Y.; Chen H.-M.; Cheng A.-L.; Lai M.-S.; KUN-HUEI YEH
臺大學術典藏	2021-01-28T01:06:23Z	Do-not-resuscitate consent signed by patients indicates a more favorable quality of end-of-life care for patients with advanced cancer	Liang Y.-H.;Wei C.-H.;Hsu W.-H.;Shao Y.-Y.;Lin Y.-C.;Chou P.-C.;Cheng A.-L.;Kun-Huei Yeh; Liang Y.-H.; Wei C.-H.; Hsu W.-H.; Shao Y.-Y.; Lin Y.-C.; Chou P.-C.; Cheng A.-L.; KUN-HUEI YEH
臺大學術典藏	2021-01-28T01:06:19Z	A Phase i study of S-1-based concurrent chemoradiotherapy followed by gemcitabine and S-1 in metastatic pancreatic adenocarcinoma	Yang S.-H.;Shao Y.-Y.;Lin C.-C.;Kuo S.-H.;Cheng A.-L.;Kun-Huei Yeh; Yang S.-H.; Shao Y.-Y.; Lin C.-C.; Kuo S.-H.; Cheng A.-L.; KUN-HUEI YEH
臺大學術典藏	2021	Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan	Tseng J.-H.; Ho M.-C.; Liao L.-Y.; Liang J.-D.; Wang C.-K.; Lee W.-C.; Shao Y.-Y.; Wang S.-Y.; Lin S.-M.; Chen K.-Y.; Lee R.-C.; Liang P.-C.; Huang K.-W.; Hu J.-T.; Kee K.-M.; Lin C.-L.; Lu S.-N.; Wang J.-H.; Chen C.-H.; Liu C.-J.; Huang Y.-H.; Wang C.-C.; Wang T.-E.; Chuang P.-H.; Dai C.-Y.; CHIUN HSU; Chen S.-C.; Hsieh C.-H.; Diagnosis Group, Systemic Therapy Group
臺大學術典藏	2020-11-27T03:25:51Z	National policies fostering hospice care increased hospice utilization and reduced the invasiveness of end-of-life care for cancer patients	Shao Y.-Y.;Hsiue E.H.-C.;Hsu C.-H.;Chien-An Yao;Chen H.-M.;Lai M.-S.;Cheng A.-L.; Shao Y.-Y.; Hsiue E.H.-C.; Hsu C.-H.; CHIEN-AN YAO; Chen H.-M.; Lai M.-S.; Cheng A.-L.
臺大學術典藏	2020-11-27T03:24:52Z	Emergency department presentation of chronic peritoneal dialysis patients	Pai M.-F.; Hsu S.-P.; Peng Y.-S.; Chiang C.-K.; Ho T.-I.; Shao Y.Y.; Lee H.-Y.; KUAN-YU HUNG
臺大學術典藏	2020-10-07T08:50:38Z	Solving the deficit of cancer pain management skills by education programs	WEN-YING LIN; Shao Y.-Y; Lin C.-P; Lu L.-C; Hsu C.-H.
臺大學術典藏	2020-08-14T03:15:30Z	Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma	Lu L.-C.; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; I-LUN SHIH; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2020-08-12T02:42:37Z	A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy	Chao Y.; Hsu C.; Lee R.-C.; Lin Z.-Z.; BANG-BIN CHEN; Hung Y.-P.; Huang P.-H.; Shen Y.-C.; Shao Y.-Y.; Hsu C.-H.; Cheng A.-L.; Lin Z.-Z.;Bang-Bin Chen;Hung Y.-P.;Huang P.-H.;Shen Y.-C.;Shao Y.-Y.;Hsu C.-H.;Cheng A.-L.;Lee R.-C.;Chao Y.;Hsu C.
臺大學術典藏	2020-08-11T08:36:55Z	Gastric perforation presenting as empyema in a patient with pancreatic cancer on bevacizumab treatment	Cheng A.-L.; Tien Y.-W.; PO-CHIN LIANG; Shao Y.-Y.; Lin Z.-Z.
臺大學術典藏	2020-08-11T08:36:51Z	A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy	Shao Y.-Y.; PO-CHIN LIANG; Wu Y.-M.; Huang C.-C.; Huang K.-W.; Cheng J.C.; Hsu C.-H.; Hsu C.; Cheng A.-L.; Lin Z.-Z.
臺大學術典藏	2020-08-07T02:32:18Z	Prognosis of patients with advanced hepatocellular carcinoma who failed first-line systemic therapy	Shao Y.-Y.; CHIH-HORNG WU; Lu L.-C.; Chan S.-Y.; Ma Y.-Y.; Yen F.-C.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2020-07-03T08:45:42Z	Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy	Shao Y.-Y;Chen B.-B;Da-Liang Ou;Lin Z.-Z;Hsu C.-H;Wang M.-J;Cheng A.-L;Hsu C.; Shao Y.-Y; Chen B.-B; DA-LIANG OU; Lin Z.-Z; Hsu C.-H; Wang M.-J; Cheng A.-L; Hsu C.
臺大學術典藏	2020-05-26T09:27:17Z	Gefitinib or erlotinib in the treatment of advanced non-small cell lung cancer.	Shao Y.Y;Lin C.C;Chih-Hsin Yang; Shao Y.Y; Lin C.C; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:27:17Z	Characteristics and risk factors of oxaliplatin-related hypersensitivity reactions	Shao Y.-Y;Hu F.-C;Liang J.-T;Chiu W.-T;Cheng A.-L;Chih-Hsin Yang; Shao Y.-Y; Hu F.-C; Liang J.-T; Chiu W.-T; Cheng A.-L; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:27:08Z	Survival of patients with small cell lung carcinoma in Taiwan	Lai M.-S.;Chih-Hsin Yang;Kuo R.N.C;Shau W.-Y;Shao Y.-Y;Yang Y.-Y;Lin Z.-Z;Kuo Y.-H; Kuo Y.-H; Lin Z.-Z; Yang Y.-Y; Shao Y.-Y; Shau W.-Y; Kuo R.N.C; CHIH-HSIN YANG; Lai M.-S.
臺大學術典藏	2020-05-26T09:27:06Z	Factors impacting prognosis prediction in BCLC stage C and Child-Pugh Class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy	Chengb A.-L.;Hsu C.-H;Hong R.-L;Chih-Hsin Yang;Chang D.-Y;Shao Y.-Y;Hu F.-C;Hsu C;Lin Z.-Z; Lin Z.-Z; Hsu C; Hu F.-C; Shao Y.-Y; Chang D.-Y; CHIH-HSIN YANG; Hong R.-L; Hsu C.-H; Chengb A.-L.

Showing items 246-270 of 396 (16 Page(s) Totally)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| Total items :0
	Visitors : 53301451 Online Users : 1038 Project Commissioned by the Ministry of Education Project Executed by National Taiwan University Library